This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BOOSTRIX TDAP vaccine syringes, a critical medical product used for infectious disease prevention. The contract has a firm fixed price of $9,572.76 and a completion date of November 26, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,863.40 firm-fixed-price contract is for the supply of BOOSTRIX TDAP vaccine syringes. The contract has an ultimate completion date of February 11, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide Boostrix TDAP vaccine syringes. The contract has a ceiling value of $24,472.32 and runs through February 24, 2023. It is a firm-fixed-price contract type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $1,021.76 firm-fixed price contract is for the supply of 4,565,913,991 units of the BOOSTRIX TDAP vaccine syringe 0.5 mL. The contract has an ultimate completion date of September 25, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of essential medical commodities, including...
This is a $3,699.02 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 0.5 mL Boostrix TDAP vaccine syringes. The contract has an ultimate completion date of August 7, 2024. AmerisourceBergen holds a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, for delivering a wide range of medical commodities to support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BOOSTRIX TDAP vaccine syringes. The contract has a ceiling value of $14,826.60 and was awarded on January 3, 2022, with a completion date of January 4, 2022. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BOOSTRIX TDAP Vaccine Syringes. The contract has a ceiling value of $26,566.80 and runs through May 1, 2023. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of BOOSTRIX TDAP vaccine syringes. The contract has a ceiling value of $6,225.12 and a completion date of January 8, 2025. It is a firm-fixed-price contract without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,198.92, is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to support military healthcare programs. The contract has a firm fixed price pricing type and an ultimate completion date of May 10, 2023. AmerisourceBergen Drug Corp is the prime contractor,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, valued at $25,778.00, with a period of performance through June 28, 2024. The contract is a firm fixed-price, delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...